Rare diseases
Investigational molecules
Locations
Back to Czechia579 clinical trials in Hradec Kralove, Czechia across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in CzechiaKlinickeTesty.cz(opens in a new tab)Study on Adjustable Brodalumab Dosage for Patients with Moderate-to-Severe Plaque Psoriasis Weighing 120 kg or More
CzechiaStudy Comparing Zanubrutinib with Bendamustine and Rituximab for Patients with Untreated Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
CzechiaLong-Term Study of Ritlecitinib Tosilate for Adults and Adolescents with Alopecia Areata
CzechiaStudy of pirtobrutinib, venetoclax and rituximab combination compared to venetoclax and rituximab in previously treated Chronic Lymphocytic Leukemia patients
CzechiaStudy of Disitamab Vedotin and Pembrolizumab for Patients with Untreated Advanced Urothelial Cancer Expressing HER2
CzechiaStudy on the Effectiveness and Safety of Pirtobrutinib vs. Ibrutinib for Patients with Previously Treated Mantle Cell Lymphoma
CzechiaStudy of ExPEC9V vaccine for preventing invasive E.
CzechiaStudy on the Effects of Obeticholic Acid and Bezafibrate for Patients with Primary Biliary Cholangitis Who Cannot Tolerate Ursodeoxycholic Acid
CzechiaStudy on the Effects and Safety of Riliprubart for Patients with Chronic Inflammatory Demyelinating Polyneuropathy Unresponsive to Usual Treatments
CzechiaStudy on Balcinrenone and Dapagliflozin for Patients with Heart Failure and Kidney Problems
CzechiaStudy on the Effectiveness and Safety of Guselkumab for Patients with Moderate to Severe Ulcerative Colitis
CzechiaStudy Comparing Savolitinib and Durvalumab with Sunitinib and Durvalumab for Patients with Advanced Papillary Renal Cell Carcinoma
CzechiaThe busiest research cities in the country
What the registry says about research in the country
Innovative research focusing on inflammatory bowel diseases, including studies evaluating new therapies for both ulcerative colitis and Crohn's disease. Clinical trials are investigating advanced treatments like OD-07656 and TAK-279 for managing moderate to severe cases.
Additional research explores antibiotic optimization and novel therapeutic combinations.
Comprehensive studies in cancer treatment, including trials for metastatic prostate cancer and advanced gastric cancers. Research focuses on innovative therapies combining targeted treatments with immunotherapy approaches.
Investigations include novel drug combinations and immunotherapy strategies.
Advanced research in multiple sclerosis and Parkinson's disease, evaluating new therapeutic approaches and comparing treatment efficacies. Studies include assessments of innovative medications and comparative analyses.
Focus on both disease-modifying treatments and symptom management.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
